Abstract:Multiple synchronous malignancies are rarer than metachronous ones. Primary synchronous breast and renal cancer is even rare. Such a case requires strict exclusion of possible metastasis to either site and to confirm the primary nature of each malignancy for better outcome of management and survival benefit. Multiple primary synchronous malignancies may be due to shared genetic mutations if any common carcinogenic factor cannot be found. The role of estrogens in cases in which human renal carcinoma is associat… Show more
“…6 The incidence of dual primary malignancy (any origin) is roughly 4-11%. 7,9 According to Jiao et al there have been 8 reported cases of synchronous breast primary malignancy coexisting with RCC. 10,18 Most of the multiple malignancies reported in literature are metastatic tumours or metachronous breast malignancy with RCC.…”
Synchronous malignancy are defined as two primary malignancy of two different organs occurring concurrently or within 6 months duration. Reports of synchronous breast carcinoma with RCC (renal cell carcinoma) are very limited. We presented here the first case of non-metastatic synchronous RCC with breast carcinoma and Paget’s disease associated with tubercular axillary lymphadenitis in a 62 year old female for which she underwent right MRM and right partial nephrectomy. She received chemotherapy and anti-tubercular therapy post-surgery and currently on oral hormonal therapy. Follow up scans showed stable disease. There have been cases of breast cancer with TB lymphadenitis as well as of double synchronous malignancies involving breast carcinoma and RCC. Most of the multiple malignancies reported in literature are metastatic tumours or metachronous breast malignancy with RCC. A case of synchronous primary ca breast with pages disease coexisting with primary RCC along with tubercular lymphadenopathy is yet to be reported in literature. This might just be the first one.
“…6 The incidence of dual primary malignancy (any origin) is roughly 4-11%. 7,9 According to Jiao et al there have been 8 reported cases of synchronous breast primary malignancy coexisting with RCC. 10,18 Most of the multiple malignancies reported in literature are metastatic tumours or metachronous breast malignancy with RCC.…”
Synchronous malignancy are defined as two primary malignancy of two different organs occurring concurrently or within 6 months duration. Reports of synchronous breast carcinoma with RCC (renal cell carcinoma) are very limited. We presented here the first case of non-metastatic synchronous RCC with breast carcinoma and Paget’s disease associated with tubercular axillary lymphadenitis in a 62 year old female for which she underwent right MRM and right partial nephrectomy. She received chemotherapy and anti-tubercular therapy post-surgery and currently on oral hormonal therapy. Follow up scans showed stable disease. There have been cases of breast cancer with TB lymphadenitis as well as of double synchronous malignancies involving breast carcinoma and RCC. Most of the multiple malignancies reported in literature are metastatic tumours or metachronous breast malignancy with RCC. A case of synchronous primary ca breast with pages disease coexisting with primary RCC along with tubercular lymphadenopathy is yet to be reported in literature. This might just be the first one.
“…The concomitant presence of breast cancer with one or more other type of cancers such as the colon, vulva, lung, larynx, liver, uterus and kidneys has been presented in the literature (4). The association of kidney cancer with synchronous and metachronous cancer in similar organs has been reported in the literature (1,5). However, reports on synchronous breast and renal cancer are very uncommon (1,4).…”
Section: Introductionmentioning
confidence: 95%
“…The association of kidney cancer with synchronous and metachronous cancer in similar organs has been reported in the literature (1,5). However, reports on synchronous breast and renal cancer are very uncommon (1,4).…”
Section: Introductionmentioning
confidence: 95%
“…The occurrence of multiple cancers in one patient is a rare phenomenon, and the frequency of synchronous neoplasms is less common than that of metachronous tumors (1). Synchronous tumors are defined as presence of a second tumor at the same time with the first tumor or within the first 6 months following diagnosis (2).…”
The concomitant presence of breast cancer with one or more other types of cancer such as colon, vulva, lung, larynx, liver, uterus and kidneys has been presented in the literature. However, synchronous breast and renal cancer is very uncommon. Herein we present a woman with synchronous breast and renal cancer, and review the literature. A 77-year-old post-menopausal woman was admitted to our clinic complaining of left sided breast mass. On physical examination, there was a 3 cm palpable mass in the upper outer quadrant of the left breast along with a conglomerate of lymph nodes in the left axilla. Ultrasonography and mammography showed a 3 cm solid, hypoechoic mass in the upper outer quadrant and left axillary lymphadenopathy. The tru-cut biopsy of the lesion revealed invasive ductal carcinoma. The bone scintigraphy, thoracic and cranial computerized tomographies were normal. The abdominal computerized tomography identified a 3x3 cm solid renal mass with heterogeneous contrast enhancement in the posterior segment of the lower pole, which was suspicious for renal cell carcinoma. Breast conserving surgery and axillary lymph node dissection was performed, and the pathology specimen demonstrated invasive ductal carcinoma. The patient was discharged on postoperative day 5. Three weeks later partial nephrectomy was performed by urology department for the solid renal mass, and the pathology result showed clear cell-renal carcinoma with Fuhrman grade 3. The patient is being followed-up for renal carcinoma, and underwent radiotherapy for breast cancer. Hormonotherapy for breast cancer is still continuing.
“…Synchronous tumors are defined as two tumors arising concurrently or within six months of diagnosis [1]. Reports of synchronous RCC and breast cancer are limited to nonmetastatic RCC and hormone receptor-positive infiltrative ductal carcinoma (IDC) treated with complete resection of each primary tumor followed by chemoradiation and hormone therapy [2, 3]. We present a case of tailored immunotherapy for a patient with concurrent metastatic RCC (mRCC) and triple-negative breast cancer (TNBC).…”
Synchronous tumors are defined as two tumors arising concurrently or within six months of each other. Reports of synchronous RCC and breast cancer are limited to nonmetastatic renal cell carcinoma (RCC) and hormone receptor-positive infiltrative ductal carcinoma. We present the first case of synchronous metastatic renal cell carcinoma and metastatic triple-negative breast cancer, managed with a novel combination of immunotherapy and chemotherapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.